Hospital
Martin Health
Martin Health was paid $3.94M by Medicaid between Jan 2018 and Dec 2024, across 76 billing codes. Its largest line is 99283, emergency room visit (moderate) — 36% of everything it billed.
33Billing provider infoMARTIN HEALTH
MARTIN, TN 38237
MARTIN, TN 38237
33aNPI1275505372assigned 02/02/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.94M
24GClaims107,160
24DCodes billed76
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Tennessee
Rank by total paid#48 of 71
Median peer was paid$6.96M
This provider vs. median0.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official PRESCOTT, TINA controls 17+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 19,792 | $481K | |
| 2019 | 19,720 | $539K | |
| 2020 | 12,999 | $468K | |
| 2021 | 16,667 | $720K | |
| 2022 | 15,464 | $722K | |
| 2023 | 14,283 | $660K | |
| 2024incomplete | 8,235 | $353K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 36% | 10,379 | 8,992 | $1.41M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 36% | 8,112 | 7,081 | $1.41M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 14% | 3,227 | 2,761 | $543K |
| 41899 | Unlisted procedure, dentoalveolar structures | 1.9% | 113 | 112 | $75K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.8% | 15,599 | 12,808 | $73K |
| 80053 | Comprehensive metabolic panel | 1.0% | 10,848 | 9,024 | $41K |
| 36415 | Collection of venous blood by venipuncture | <1% | 20,285 | 14,932 | $36K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,599 | 3,937 | $34K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,283 | 1,140 | $31K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 218 | 181 | $22K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 874 | 741 | $18K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,845 | 1,255 | $16K |
64 more codes
| 71046 | Radiologic examination, chest; 2 views | <1% | 320 | $16K |
| 59025 | Fetal non-stress test | <1% | 524 | $15K |
| 84484 | <1% | 1,352 | $15K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 994 | $15K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 404 | $13K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,710 | $12K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,520 | $10K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,945 | $10K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 326 | $9K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 141 | $9K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 376 | $8K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 488 | $8K |
| G0378 | Hospital observation service, per hour | <1% | 41 | $7K |
| 87040 | <1% | 905 | $6K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 197 | $6K |
| 87430 | <1% | 741 | $6K | |
| 81001 | <1% | 6,246 | $6K | |
| 97597 | <1% | 160 | $5K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 625 | $5K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 665 | $4K |
| 80061 | Lipid panel | <1% | 526 | $4K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 14 | $4K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 69 | $3K |
| 81003 | <1% | 2,375 | $3K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 243 | $3K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 126 | $2K |
| 81025 | <1% | 704 | $2K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 50 | $2K |
| 84439 | <1% | 474 | $2K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 27 | $2K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 235 | $2K |
| 83605 | <1% | 332 | $2K | |
| 87400 | <1% | 371 | $1K | |
| 83874 | <1% | 181 | $1K | |
| 84703 | <1% | 210 | $1K | |
| 72100 | <1% | 19 | $1K | |
| 86140 | <1% | 210 | $646.94 | |
| 87081 | <1% | 117 | $545.97 | |
| 87807 | <1% | 63 | $519.42 | |
| 80306 | <1% | 110 | $492.70 | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 13 | $482.44 |
| 93017 | <1% | 17 | $369.31 | |
| 83735 | <1% | 66 | $268.97 | |
| 80076 | <1% | 62 | $212.66 | |
| 83690 | <1% | 61 | $207.72 | |
| 87088 | <1% | 28 | $180.41 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 16 | $153.38 |
| 83880 | <1% | 31 | $151.11 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 54 | $143.04 |
| 80051 | <1% | 30 | $121.23 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 13 | $97.90 |
| 84145 | <1% | 16 | $92.52 | |
| 82962 | <1% | 27 | $53.56 | |
| 85610 | <1% | 56 | $52.85 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 15 | $51.39 |
| 85730 | <1% | 14 | $16.10 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 14 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 27 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 14 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 14 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 14 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 14 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 14 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPRESCOTT, TINA (PRESIDENT AND CEO)
| Provider | Location | Paid |
|---|---|---|
| Jackson Madison County General Hospital | Jackson, TN | $46.51M |
| Pathways of Tennessee, INC. | Jackson, TN | $30.54M |
| Dyersburg Health | Dyersburg, TN | $13.19M |
| Jackson-Madison County General Hospital | Jackson, TN | $12.97M |
| Jackson-Madison County General Hospital | Jackson, TN | $7.37M |
| WT Medical Associates | Dyersburg, TN | $5.52M |
| West Tennessee Healthcare Henry County | Paris, TN | $4.47M |
| Therapy & Learning Center INC | Jackson, TN | $4.19M |
| Milan General Hospital, INC. | Milan, TN | $3.54M |
| Camden General Hospital, INC. | Camden, TN | $3.46M |
| Pathways of Tennessee, INC. | Jackson, TN | $3.30M |
| Bolivar General Hospital, INC. | Bolivar, TN | $2.36M |
| Martin Health | South Fulton, TN | $1.47M |
| Lift Therapy, INC. | Jackson, TN | $778K |
| Jackson-Madison County General Hospital | Jackson, TN | $449K |
| West Tennessee Healthcare Henry County | Paris, TN | $136K |
| Jackson-Madison County General Hospital | Jackson, TN | $108K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.